208 related articles for article (PubMed ID: 24820861)
1. Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy.
Ruiz Ramos J; Roma E; Palomar L; Poveda JL
Chemotherapy; 2013; 59(5):344-5. PubMed ID: 24820861
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer.
Méndez LE; Mueller A; Salom E; González-Quintero VH
Obstet Gynecol; 2003 Nov; 102(5 Pt 2):1200-2. PubMed ID: 14607056
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma.
Hubalek M; Smekal-Schindelwig C; Zeimet AG; Sergi C; Brezinka C; Mueller-Holzner E; Marth C
Arch Gynecol Obstet; 2007 Aug; 276(2):179-83. PubMed ID: 17342499
[TBL] [Abstract][Full Text] [Related]
4. Combined chemotherapy with paclitaxel and carboplatin for mucinous cystadenocarcinoma of the ovary during pregnancy.
Doi D; Boh Y; Konishi H; Asakura H; Takeshita T
Arch Gynecol Obstet; 2009 Oct; 280(4):633-6. PubMed ID: 19205713
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S; Scambia G; Katsaros D; Gallo C; Pujade-Lauraine E; De Placido S; Bologna A; Weber B; Raspagliesi F; Panici PB; Cormio G; Sorio R; Cavazzini MG; Ferrandina G; Breda E; Murgia V; Sacco C; Cinieri S; Salutari V; Ricci C; Pisano C; Greggi S; Lauria R; Lorusso D; Marchetti C; Selvaggi L; Signoriello S; Piccirillo MC; Di Maio M; Perrone F; ; ; ; ;
Lancet Oncol; 2014 Apr; 15(4):396-405. PubMed ID: 24582486
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.
Sood AK; Shahin MS; Sorosky JI
Gynecol Oncol; 2001 Dec; 83(3):599-600. PubMed ID: 11733979
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
[TBL] [Abstract][Full Text] [Related]
9. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
Bamias A; Papadimitriou C; Efstathiou E; Rodolakis A; Vlahos G; Voulgaris Z; Bozas G; Fountzilas G; Aravantinos G; Razis E; Gika D; Dimopoulos MA
BMC Cancer; 2006 Sep; 6():228. PubMed ID: 16999858
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer in pregnancy.
Fruscio R; de Haan J; Van Calsteren K; Verheecke M; Mhallem M; Amant F
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():108-117. PubMed ID: 28029502
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
[TBL] [Abstract][Full Text] [Related]
12. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review.
Karimi Zarchi M; Behtash N; Modares Gilani M
Arch Gynecol Obstet; 2008 Jan; 277(1):75-8. PubMed ID: 17653741
[TBL] [Abstract][Full Text] [Related]
13. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T
Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
[TBL] [Abstract][Full Text] [Related]
14. Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review.
Picone O; Lhommé C; Tournaire M; Pautier P; Camatte S; Vacher-Lavenue MC; Castaigne D; Morice P
Gynecol Oncol; 2004 Aug; 94(2):600-4. PubMed ID: 15297214
[TBL] [Abstract][Full Text] [Related]
15. Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review.
Ferrandina G; Distefano M; Testa A; De Vincenzo R; Scambia G
Gynecol Oncol; 2005 May; 97(2):693-6. PubMed ID: 15863184
[TBL] [Abstract][Full Text] [Related]
16. Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial.
Potamianou A; Androulakis N; Papakotoulas P; Toufexi H; Latoufis C; Kouroussis C; Christofilakis C; Xenidis N; Georgoulias V; Polyzos A
Oncology; 2005; 69(4):348-53. PubMed ID: 16293974
[TBL] [Abstract][Full Text] [Related]
17. A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcome.
Bamias A; Bamia C; Karadimou A; Soupos N; Zagouri F; Rodolakis A; Haidopoulos D; Vlahos G; Thomakos N; Antsaklis A; Dimopoulos MA
Oncology; 2011; 81(5-6):365-71. PubMed ID: 22248920
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy.
Seamon LG; Downey GO; Harrison CR; Doss B; Carlson JW
Gynecol Oncol; 2009 Sep; 114(3):540-1. PubMed ID: 19523669
[No Abstract] [Full Text] [Related]
19. Three-hour paclitaxel infusion and carboplatin is an effective outpatient treatment for stage III epithelial ovarian cancer.
Brown JV; Rettenmaier MA; Dillman RA; Birk CL; Culkin K; Micha JP
Gynecol Oncol; 1998 Feb; 68(2):166-8. PubMed ID: 9514805
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin and short-infusion paclitaxel in high-risk and advanced-stage ovarian carcinoma.
Coleman RL; Bagnell KG; Townley PM
Cancer J Sci Am; 1997; 3(4):246-53. PubMed ID: 9263631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
